CEO and Chairman of Board, 10% Owner of Pain Therapeutics (PTIE) Remi Barbier sells 50,000 shares of PTIE on 06/03/2010 at an average price of $5.53 a share.

Pain Therapeutics has a market cap of $236.5 million; its shares were traded at around $5.59 with and P/S ratio of 11.5.

PTIE is in the portfolios of Richard Perry of Perry Capital, Jim Simons of Renaissance Technologies LLC.

This is the annual revenues and earnings per share of PTIE over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of PTIE.

CEO Recent Trades:

• Sell:: CEO and Chairman of BOD, 10% Owner Remi Barbier sold 6,576 shares of PTIE stock on 05/06/2010 at the average price of 5.61, the price of the stock has decreased by 0.36% since.


• Sell:: CEO and Chairman of BOD, 10% Owner Remi Barbier sold 43,424 shares of PTIE stock on 05/05/2010 at the average price of 5.91, the price of the stock has decreased by 5.41% since.


• Sell:: CEO and Chairman of Board, 10% Owner Remi Barbier sold 5,800 shares of PTIE stock on 04/07/2010 at the average price of 6.23, the price of the stock has decreased by 10.27% since.


• Sell:: CEO & Chairman of the Board, 10% Owner Remi Barbier sold 32,200 shares of PTIE stock on 04/06/2010 at the average price of 6.25, the price of the stock has decreased by 10.56% since.


• Sell:: CEO and Chairman of the Board, 10% Owner Remi Barbier sold 12,000 shares of PTIE stock on 04/01/2010 at the average price of 6.16, the price of the stock has decreased by 9.25% since.

This is the insider trade history vs. stock price of PTIE. For the complete insider trading history of PTIE, click here.

Directors and Officers Recent Trades:

• Sell:: Chief Scientific Officer Grant Schoenhard sold 10,979 shares of PTIE stock on 05/27/2010 at the average price of 5.74, the price of the stock has decreased by 2.61% since.


• Sell:: Chief Scientific Officer Grant Schoenhard sold 2,486 shares of PTIE stock on 05/19/2010 at the average price of 5.77, the price of the stock has decreased by 3.12% since.


• Sell:: Chief Scientific Officer Grant Schoenhard sold 13,035 shares of PTIE stock on 05/18/2010 at the average price of 5.77, the price of the stock has decreased by 3.12% since.


• Sell:: COO Nadav Friedmann sold 15,000 shares of PTIE stock on 05/04/2010 at the average price of 5.95, the price of the stock has decreased by 6.05% since.


• Sell:: Chief Scientific Officer Grant Schoenhard sold 26,500 shares of PTIE stock on 04/16/2010 at the average price of 6.29, the price of the stock has decreased by 11.13% since.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool